Breast Cancer Follow-Up and Surveillance After Primary Treatment Guideline Update
Drs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and Lustberg explain the n...
26 Elo 19min
Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline 2026.1.0
Drs. Jamie Lesnock and Sara Bouberhan join the podcast to discuss the first ASCO guideline on systemic treatment for recurrent ovarian cancer. They provide a comprehensive overview of the evidence-bas...
24 Elo 21min
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.2
Dr. Sonam Puri joins the podcast to share the update to the living guideline on stage IV NSCLC with driver alterations. Dr. Puri discusses the practice-changing evidence reviewed for both NTRK rearran...
28 Heinä 9min
Treatment of Multiple Myeloma: ASCO Living Guideline Update 2026.1.1
Dr. Rahul Banerjee joins the podcast to discuss the latest update to the living guideline on the treatment of multiple myeloma. He explains how sensational results from the MajesTEC-3 trial, which eva...
29 Kesä 17min
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline
Drs. Tina Lockwood and Stacy Gray share the newly released evidence-based guideline on circulating tumor DNA (ctDNA) testing from ASCO. They highlight recommendations on when ctDNA testing should be o...
18 Kesä 17min
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2
Dr. Joshua Reuss returns to the podcast to discuss the update to the living guideline on stage IV NSCLC with driver alterations. The conversation focuses on new cancer treatment strategies for patient...
26 Touko 19min
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1
Dr. Lyudmila Bazhenova joins the podcast to share the update to the living guideline on stage IV NSCLC without driver alterations. Dr. Bazhenova discusses the evidence reviewed for both non-squamous N...
26 Touko 13min
Systemic Treatment of Thyroid Cancer Guideline
Dr. Nabil Saba shares the first evidence-based guideline on thyroid cancer from ASCO. He highlights recommendations on first- and subsequent-line systemic treatment – including multikinase inhibitors ...
1 Huhti 23min
